A 24f with complaints of giddiness . VIT D3 level -5. What is the treatment
Reading File
Finding Sources
Searching PubMed
"vitamin D deficiency" AND treatment
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Searching the Web
vitamin D3 level 5 ng/mL severe deficiency treatment protocol 2024
I now have enough information to give a thorough, well-sourced answer.
Vitamin D3 = 5 ng/mL - Severe Deficiency: Assessment & Treatment
A 24-year-old female with a 25(OH)D level of 5 ng/mL has severe Vitamin D deficiency (defined as <12 ng/mL by most guidelines; some classify <5 ng/mL as extremely severe). Giddiness (dizziness/lightheadedness) in this context is a recognized manifestation of hypovitaminosis D, likely related to proximal muscle weakness and possibly hypocalcemia secondary to the deficiency.
Understanding the Level
| Status | 25(OH)D Level |
|---|---|
| Sufficient | >30 ng/mL |
| Insufficient | 21-29 ng/mL |
| Deficient | <20 ng/mL |
| Severely deficient | <12 ng/mL |
| Critically low (this patient) | 5 ng/mL |
Step 1 - Rule Out Complications First
Before starting supplementation, check:
- Serum calcium (hypocalcemia from prolonged deficiency can cause tetany, seizures)
- PTH (secondary hyperparathyroidism is expected at this level)
- Serum phosphate
- Renal function (to choose the right form of Vit D)
- ALP (elevated in osteomalacia)
Step 2 - Treatment Protocol (Adult, 24F, No Malabsorption)
Phase 1: Loading/Repletion (First 8-12 Weeks)
The goal is to rapidly raise 25(OH)D levels to >30 ng/mL.
Preferred option - Weekly high-dose:
Vitamin D3 (Cholecalciferol) 60,000 IU once weekly for 8-12 weeks (orally)
This is the most widely used regimen in clinical practice, particularly in India and South Asia. It equals ~6,000-8,000 IU/day cumulatively.
Alternative - Daily dosing (per Harrison's 22nd Ed):
50,000 IU/week for 6-8 weeks, followed by maintenance
Or daily: 6,000 IU/day for 8 weeks (per Endocrine Society guidelines for severe deficiency)
Note: Vitamin D3 (cholecalciferol) is preferred over D2 (ergocalciferol) as it is more potent and raises serum levels more effectively. - Harrison's Principles of Internal Medicine 22E, 2025
Phase 2: Maintenance (After repletion)
Vitamin D3 800-2000 IU/day (or 60,000 IU once monthly) indefinitely
Step 3 - Calcium Supplementation
At a level this low, co-prescribe calcium:
- Calcium carbonate 500-1000 mg twice daily with food (provides ~1000-1500 mg elemental calcium/day)
- Calcium should be taken with food for better absorption
- Separate calcium and iron supplements by at least 2 hours
Step 4 - Address the Giddiness
Giddiness in severe Vit D deficiency may be due to:
- Proximal muscle weakness affecting balance and posture
- Hypocalcemia (if present) causing neuromuscular irritability
- Orthostatic hypotension (less common)
Giddiness typically improves within 4-8 weeks of adequate supplementation once levels normalize.
Step 5 - Lifestyle & Sunlight
- Encourage 15-30 minutes of direct sun exposure (arms and legs) between 10 AM and 3 PM, at least 3-4 times per week
- Dietary sources: fatty fish (salmon, mackerel), egg yolks, fortified milk/cereals
- Address risk factors: poor sun exposure, indoor lifestyle, dark skin, covered clothing
Step 6 - Monitoring
- Recheck 25(OH)D levels after 8-12 weeks of loading therapy
- Target: 25(OH)D >30 ng/mL (ideally 40-60 ng/mL)
- Also recheck calcium, PTH, and phosphate
- Adjust maintenance dose based on response
Safety / Toxicity
The upper safe limit is 4,000 IU/day for long-term use; therapeutic loading doses above this are safe for short durations (8-12 weeks) under supervision. Toxicity (hypercalcemia) is rare at these doses. - Harrison's 22E
Summary Treatment Card
| Phase | Regimen | Duration |
|---|---|---|
| Loading | Vit D3 60,000 IU once weekly | 8-12 weeks |
| Calcium | 500 mg elemental Ca twice daily | Ongoing |
| Maintenance | Vit D3 1,000-2,000 IU/day | Lifelong or per recheck |
| Recheck | 25(OH)D + Ca + PTH | After 8-12 weeks |
Sources: Harrison's Principles of Internal Medicine 22E (2025), Endocrine Society Clinical Practice Guideline 2024, Goldman-Cecil Medicine International Edition
This is a shared conversation. Sign in to Orris to start your own chat.